ACAD
38.07
+2.16
+6.02%
AEMD
7.85
+0.25
+3.29%
APRI
1.69
-0.09
-5.06%
ARNA
2.7
+0.14
+5.47%
ATEC
0.57
-0.01
-1.72%
CNAT
3.97
+0.24
+6.43%
CRXM
0.35
0.00
0.00%
CYTX
0.353
-0.027
-7.0263%
DXCM
89.37
+1.55
+1.76%
GNMK
9.81
+0.15
+1.55%
HALO
17.54
+0.92
+5.54%
ILMN
198.11
+4.98
+2.58%
INNV
0.11
-0.02
-15.3965%
INO
7.23
+0.13
+1.83%
ISCO
3.7
-0.1
-2.63%
ISIS
51.75
+3
+6.15%
LGND
92.42
+3.94
+4.45%
LPTN
0.242
-0.009
-3.4000%
MBVX
1.685
-0.115
-6.389%
MEIP
1.86
+0.06
+3.33%
MNOV
3.14
+0.09
+2.95%
MRTX
27.84
+1.27
+4.78%
MSTX
0.476
-0.004
-0.8125%
NBIX
49.63
+2.58
+5.48%
NUVA
52.15
+0.14
+0.27%
ONCS
5.76
-0.01
-0.17%
ONVO
2.64
+0.19
+7.76%
OREX
2.745
+0.065
+2.425%
OTIC
22.39
+0.94
+4.38%
QDEL
21.45
+1.17
+5.77%
RCPT
231.96
0.00
0.00%
RGLS
9.24
+0.98
+11.86%
RMD
51.91
+1.16
+2.29%
SCIE
0.014
0.00
0.00%
SPHS
0.85
0.00
0.00%
SRNE
13.32
+0.86
+6.90%
TROV
6.33
+0.61
+10.66%
VICL
0.601
-0.01
-1.5574%
VOLC
18
0.00
0.00%
ZGNX
20.5
+2.02
+10.93%
ACAD
38.07
+2.16
+6.02%
AEMD
7.85
+0.25
+3.29%
APRI
1.69
-0.09
-5.06%
ARNA
2.7
+0.14
+5.47%
ATEC
0.57
-0.01
-1.72%
CNAT
3.97
+0.24
+6.43%
CRXM
0.35
0.00
0.00%
CYTX
0.353
-0.027
-7.0263%
DXCM
89.37
+1.55
+1.76%
GNMK
9.81
+0.15
+1.55%
HALO
17.54
+0.92
+5.54%
ILMN
198.11
+4.98
+2.58%
INNV
0.11
-0.02
-15.3965%
INO
7.23
+0.13
+1.83%
ISCO
3.7
-0.1
-2.63%
ISIS
51.75
+3
+6.15%
LGND
92.42
+3.94
+4.45%
LPTN
0.242
-0.009
-3.4000%
MBVX
1.685
-0.115
-6.389%
MEIP
1.86
+0.06
+3.33%
MNOV
3.14
+0.09
+2.95%
MRTX
27.84
+1.27
+4.78%
MSTX
0.476
-0.004
-0.8125%
NBIX
49.63
+2.58
+5.48%
NUVA
52.15
+0.14
+0.27%
ONCS
5.76
-0.01
-0.17%
ONVO
2.64
+0.19
+7.76%
OREX
2.745
+0.065
+2.425%
OTIC
22.39
+0.94
+4.38%
QDEL
21.45
+1.17
+5.77%
RCPT
231.96
0.00
0.00%
RGLS
9.24
+0.98
+11.86%
RMD
51.91
+1.16
+2.29%
SCIE
0.014
0.00
0.00%
SPHS
0.85
0.00
0.00%
SRNE
13.32
+0.86
+6.90%
TROV
6.33
+0.61
+10.66%
VICL
0.601
-0.01
-1.5574%
VOLC
18
0.00
0.00%
ZGNX
20.5
+2.02
+10.93%
Home » Archive by Category

Xconomy

From Iceland to White House, Precision Medicine’s Promises & Hurdles

March 31, 2015 – 3:30 am

There is talk, and there is action. In the drive toward healthcare tailored for smaller and smaller groups of people, there was both last week, and both illustrated not just the promise of precision…

[[Click headline to continue reading.]]

From Iceland to White House, Precision Medicine’s Promises & Hurdles

March 31, 2015 – 3:30 am

[Updated and corrected, 4/5/15, 6:51 pm. See below.] There is talk, and there is action. In the drive toward healthcare tailored for smaller and smaller groups of people, there was both last week,…

[[Click headline to continue reading.]]

Teva Agrees to Buy San Diego’s Auspex Pharmaceuticals for $3B+

March 30, 2015 – 9:09 am

Israel’s Teva Pharmaceutical Industries (NYSE: TEVA) says today it has agreed to acquire San Diego-based Auspex Pharmaceuticals (NASDAQ: ASPX) in a cash deal valued between $3.2 billion and $3.5…

[[Click headline to continue reading.]]

In Mental Health Therapy, Cautious Steps Toward the Pharmacodigital

March 17, 2015 – 3:30 am

[Corrected 3/17/15, 7:55 pm. See below.] The phrase “better living through chemistry,” derived from an old DuPont corporate slogan, has accumulated all kinds of ironic and wink-wink…

[[Click headline to continue reading.]]

Admetsys Wins Top Prize at SXSW Hatch Pitch, Astroprint and Plum Follow

March 16, 2015 – 2:16 pm

Part of the value pitching in a competition at South by Southwest is getting to speak to a room packed with potential investors and users. But winning, and the prizes that come with it, never hurts….

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More

March 13, 2015 – 7:37 am

A is for all the news up and down the West Coast this week, and much of that news was both about bio and tech. Apple launched an iPhone-based medical research platform, 23andMe has hired a former…

[[Click headline to continue reading.]]

After Raising $60M, Kura Oncology Renews Work on Shelved Cancer Drug

March 12, 2015 – 4:30 am

[Updated 3/12/15 9:55 am.] Even after the FDA refused to approve the anti-cancer drug tipifarnib in 2005, some experts could see a tantalizing glimmer of potential for patients with acute myeloid…

[[Click headline to continue reading.]]

After Raising $60M, Kura Oncology Renews Work on Shelved Cancer Drug

March 12, 2015 – 4:30 am

[Updated 3/12/15 9:55 am.] Even after the FDA refused to approve the anti-cancer drug tipifarnib in 2005, some experts could see a tantalizing glimmer of potential for patients with acute myeloid…

[[Click headline to continue reading.]]

At Acadia, “Mistakes Were Made,” A Drug Is Delayed & the CEO Is Out

March 11, 2015 – 4:06 pm

On Tuesday, Acadia Pharmaceuticals dropped out of two conferences and its stock price jumped, apparently because investors thought an acquisition was coming. Not quite. Instead San Diego-based Acadia…

[[Click headline to continue reading.]]

At Acadia, “Mistakes Were Made,” A Drug Is Delayed & the CEO Is Out

March 11, 2015 – 4:06 pm

On Tuesday, Acadia Pharmaceuticals dropped out of two conferences and its stock price jumped, apparently because investors thought an acquisition was coming. Not quite. Instead San Diego-based Acadia…

[[Click headline to continue reading.]]